WEF25: Saudi Foreign Minister Says Middle East Has “Opportunity to Turn a Page” Following Gaza Ceasefire
22.1.2025 13:25:00 CET | Business Wire | Press release
Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, today said the Middle East has an opportunity to shape a prosperous future following the Gaza ceasefire deal which came into effect at the start of the week.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121797711/en/
Saudi Arabia’s Minister of Foreign Affairs, His Highness Prince Faisal bin Farhan bin Abdullah, addressed a panel session at the World Economic Forum Annual Meeting 2025 in Davos on ‘Diplomacy amid Disorder’, where he spoke about an opportunity for the region “to turn a page” (Photo: AETOSWire)
“We are certainly in a region that is abundant with risk factors. But we are also in a region that has huge potential. Even with a very difficult year behind us, we have shown we can be resilient as a region and we can look to the future, whether it’s the Kingdom, the GCC countries and their ability to stay on track with their economic agendas. But also, as we see now with Syria, Lebanon, and possibly now in Gaza – there is positivity there.
“The opportunity to turn a page exists in the whole region. I choose to be optimistic,” the Saudi Minister of Foreign Affairs said.
His Excellency Ahmed A. Al-Khateeb, Minister of Tourism, in a session titled ‘Travel and Tourism’s Role in Building Trust,’ commented: “Since opening our doors back in 2019, we’ve been blessed to receive millions of international arrivals. We started with 10 million tourists in 2019, and last year hit almost 30 million. Travel and tourism is contributing to building a diversified and more resilient economy.”
During a Saudi House panel session on ‘New Approaches to Measuring Growth Beyond GDP’, His Excellency Mohammed A. Aljadaan, Minister of Finance, emphasized that growth should not be limited to GDP alone. He highlighted the importance of monitoring additional indicators to ensure that growth is both inclusive and sustainable across various dimensions.
Speaking in a panel on ‘The Future of Growth’, His Excellency Faisal F. Alibrahim, Minister of Economy and Planning, highlighted the Kingdom’s long-term approach to growth: “Saudi Vision 2030 is an example of bold leadership that has led us to plan with confidence, deliver with optimism, but also manage with prudence.”
The WEF released a briefing paper with expert input from HE Al-Khateeb, Minister of Tourism, on ‘The Future of Travel and Tourism: Embracing Sustainable and Inclusive Growth’ exploring trends in the sector and the importance of cross-sector collaboration. The Ministry of Tourism also released an Investor White Paper highlighting initiatives transforming the Kingdom's tourism sector under Vision 2030.
During a Saudi House session hosted by the Ministry of Investment and Ministry of Communications and Information Technology, Salesforce announced plans to open a new regional headquarters in Riyadh, pledging to provide upskilling opportunities to 30,000 Saudi citizens by 2030. The firm also announced a partnership agreement with IBM to open an AI Innovation Center in the Kingdom.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250121797711/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom